From:
Research by Columbia Business School’s Professor Frank Lichtenberg was featured in The Hill Times in an article on innovative medicines. In the piece by Dr. Bettina Hamelin, Professor Lichtenberg’s research is cited to highlight how sustained investment in pharmaceutical innovation can reduce hospital stays and overall healthcare costs.
